The OTC Space | Tag Archive

Crossing the Line | ISDA Media Comment

May 3, 2013 by Mihir Vaidya 1 Comment

An interesting post over at ISDA media comment on the alleged resistance from major central banks and foreign regulators to cross-border derivatives regulation. The post highlights the author’s views on the original article published in the NY times (link here), which projects the concerns of global policy makers as a hindrance to regulators rather than […]

News

cftc, cross-border, derivatives, otc

Some traders expect OTC volumes dip from CFTC KYC rule | IFR report

May 2, 2013 by Mihir Vaidya 3 Comments

The documentation protocols for buy-side accounts under the CFTC regulations went into effect on May 1, 2013. Despite warnings from dealers in the months leading up to the May 1st timeline, it appears that a significant percentage of buy-side firms did not sign up to the protocols (requiring them to disclose detailed information to their […]

Dodd Frank, IFR, News

buy-side, cftc, kyc, otc, swaps

Asian Fund Managers brace for the FTT and new OTC regulations

April 18, 2013 by Mihir Vaidya 1 Comment

An interesting article on the concerns of fund managers in Asia, specifically with regards to the extra-territorial implications of the proposed European Financial Transaction Tax (FTT) and new OTC regulations such as EMIR. The full article can be found here Key Highlights: Impact of the FTT: Impact on financing and collateral: The FTT will not […]

News

Asia, EMIR, FTT, otc, regulations

Can pitfalls of Central Clearing be avoided?

April 15, 2013 by Maria Leontiou 0 Comments

OTC clearing processes are officially up and running since March 11th for the US category 1 firms, but at the same time operational risk fears build up as market participants strive to fine tune all parts of the clearing chain. The industry realizes that it’s not a UAT period any more, it’s the real thing […]

Clearing, Dodd–Frank Wall Street Reform and Consumer Protection Act, Operational risk, otc, Risk management

IOSCO publishes comments to Feb 15 Consultative Paper on Margin for Un-cleared Derivs

April 3, 2013 by Mihir Vaidya 0 Comments

IOSCO yesterday published the comments received on the second consultative paper for uncleared derivatives on their website. All responses from industry participants are available under ‘View Comments’ here. Michael Beaton from Regulatory Reform has published a summary of some key industry responses here. There are some very interesting comments, especially from ISDA on the issue […]

bilateral, collateral, consultative document, consultative paper, derivatives, hypothecation, Initial Margin, isda, otc

Optimizing the Cost of Customization for OTC Derivatives End Users

March 28, 2013 by Jon Skinner 0 Comments

Optimizing the Cost of Customization for OTC Derivatives End Users For those of you who haven’t seen it I recommend the article with the above title in the paper at the attached link (starts on page 69) published by the Institute for Financial Markets and written by Sean Owens from Woodbine Associates (a research-based consulting […]

Basel III, bilateral, cftc, cleared, Initial Margin, o malia, otc, otc derivatives

OTC Derivatives – News Digest – 18.3.2013

March 19, 2013 by Tom Riesack 2 Comments

Dear Reader, Starting this week you receive a compilation of news items (thus “News Digest”) from the week that just went. A short summary of highlights precedes the article abstracts and corresponding links. A number of those are from sources like Risk or FT, which obviously require a subscription. Some of the items are abstracts […]

A Reality check for the Derivatives Industry | FT

March 18, 2013 by Mihir Vaidya 1 Comment

Interesting article in FT discussing the impact of DFA and other regulations on both listed and OTC derivatives markets. A new worry besetting the derivatives industry for the first time in 30 years – growth. Given the continual slump in global economic growth and near-zero interest rates in the financially developed markets, is the timing […]

News

derivatives, dfa, otc, regulations

ISDA emphasises the importance of non-cleared OTC derivatives

March 14, 2013 by Tom Riesack 1 Comment

ISDA have published a 27-page report making the case for non-cleared derivatives. It is a very good read and brings to light what types of derivatives will stay out of central clearing and why. Between the lines it connects the dots between non-cleared OTC derivatives and the intended margining requirements currently being looked into by […]